脓毒症的免疫调理治疗

The immunomodulating therapy for sepsis

严重脓毒症疗效差，死亡率高，是当代重症医学的焦点和难点问题。随着对脓毒症炎症和免疫病理生理过程认识的深入，其治疗经历了单纯抗炎治疗、拮抗炎性细胞闽子、综合免疫调理治疗多个阶段。综合免疫调理治疗比单一因素治疗显示出较好的效果，为未来脓毒症治疗带来更多希望。

Severe sepsis, with its high mortality and bad therapeutic effect, remains one of the toughest problems in current critical care. Along with the progress of the cognition of the pathophysiological derangement of inflammation and immune in sepsis, the therapy for sepsis has evolved from simple anti - inflammatory therapy,inflammatory antagonizing therapy to combined immunomodulating therapy. Combined immunomodulating therapy shows more active effect than the therapy aimed directly at single agent thus reveals a better perspective for future treatment of sepsis.